Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients October 6, 2021
Relationship between physical activity time and intramuscular adipose tissue content of the thigh muscle groups of younger and older men October 5, 2021
Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma October 5, 2021
Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study October 5, 2021
Label-free photothermal disruption of cytotoxic aggregates rescues pathology in a C. elegans model of Huntington’s disease October 5, 2021
Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases October 5, 2021
The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts October 5, 2021
Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma? October 5, 2021
Evaluating posterior vitreous detachment by widefield 23-mm swept-source optical coherence tomography imaging in healthy subjects October 5, 2021
Deep learning for predicting uncorrected refractive error using posterior segment optical coherence tomography images October 5, 2021
Dysregulated non-coding telomerase RNA component and associated exonuclease XRN1 in leucocytes from women developing preeclampsia-possible link to enhanced senescence October 5, 2021
Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization October 5, 2021
Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization October 5, 2021
Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure October 4, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia October 4, 2021